Pharmacotherapy considerations in transgender individuals living with human immunodeficiency virus
- PMID: 33404067
- PMCID: PMC8128446
- DOI: 10.1002/phar.2499
Pharmacotherapy considerations in transgender individuals living with human immunodeficiency virus
Abstract
Pharmacotherapy considerations are often a concern for transgender individuals who are living with human immunodeficiency virus (HIV) due to concerns for drug-drug interactions between their hormone and antiretroviral therapies. Many of the first-line therapies offered to patients for the management of HIV have reduced concerns for safety, resistance, and drug-drug interactions. In this review, we highlight common medications and important considerations for caring for transgender people living with HIV.
Keywords: antiretroviral therapy; hormone therapy; human immunodeficiency virus; transgender.
© 2021 Pharmacotherapy Publications, Inc.
Conflict of interest statement
Conflict of Interest Statement: None of the authors have any conflicts to disclose.
References
-
- Centers for Disease Control and Prevention (CDC). HIV and Transgender People. Available from: https://www.cdc.gov/hiv/group/gender/transgender/index.html. Accessed September 3, 2020.
-
- GLAAD (Gay and Lesbian Alliance Against Defamation). Accelerating Acceptance 2017 (A Harris Poll survey). Available from: http://www.glaad.org/files/aa/2017_GLAAD_Accelerating_Acceptance.pdf. Accessed September 3, 2020.
-
- Flores AR, Herman JL, Gates GJ, Brown TNT. How many adults identify as transgender in the United States? The Williams Institute, Los Angeles, CA. 2016. Available from: https://williamsinstitute.law.ucla.edu/wp-content/uploads/How-Many-Adult.... Accessed September 3, 2020.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
